Short interest in Viracta Therapeutics Inc (NASDAQ:VIRX) increased during the last reporting period, rising from 1.10M to 2.69M. This put 8.68% of the company's publicly available shares short.

Short interest for Viracta Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Viracta Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 2.76M shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.